Global Health Technologies Coalition’s “Breakthroughs”: The latest in MERS R&D: Do we have the tools needed to prevent the next outbreak?
Kat Kelley, GHTC’s senior program assistant, reviews research and development efforts on vaccines and drugs for Middle East Respiratory Syndrome. She writes, “…Researchers and public health advocates alike are wondering: will we learn from the Ebola outbreak and invest in R&D to create the tools needed to respond to a MERS pandemic, or will we wait until it’s too late?” (8/12).